Abstract:Mitophagy, a selective autophagic process, has emerged as a pathway involved in degrading dysfunctional mitochondria. Herein, new platinum(II)-based chemotherapeutics with mitophagy-targeting properties were proposed. Four novel binuclear anticancer Pt(II) complexes with 4′-substituted-2,2′:6′,2′′-terpyridine derivatives (tpy1–tpy4), i.e., [Pt2(tpy1)(DMSO)2Cl4]CH3OH (tpy1Pt), [Pt(tpy2)Cl][Pt(DMSO)Cl3]CH3COCH3 (tpy2Pt), [Pt(tpy3)Cl][Pt(DMSO)Cl3] (tpy3Pt), and [Pt(tpy4)Cl]ClCH3OH (tpy4Pt), were designed and prepared. Moreover, their potential antitumor mechanism was studied. Tpy1Pt–tpy4Pt exhibited more selective cytotoxicity against cisplatin-resistant SK-OV-3/DDP (SKO3cisR) cancer cells compared with those against ovarian SK-OV-3 (SKO3) cancer cells and normal HL-7702 liver (H702) cells. This selective cytotoxicity of Tpy1Pt–tpy4Pt was better than that of its ligands (i.e., tpy1–tpy4), the clinical drug cisplatin, and cis-Pt(DMSO)2Cl2. The results of various experiments indicated that tpy1Pt and tpy2Pt kill SKO3cisR cancer cells via a mitophagy pathway, which involves the disruption of the mitophagy-related protein expression, dissipation of the mitochondrial membrane potential, elevation of the [Ca2+] and reactive oxygen species levels, promotion of mitochondrial DNA damage, and reduction in the adenosine triphosphate and mitochondrial respiratory chain levels. Furthermore, in vivo experiments indicated that the dinuclear anticancer Pt(II) coordination compound (tpy1Pt) has remarkable therapeutic efficiency (ca. 52.4%) and almost no toxicity. Therefore, the new 4′-substituted-2,2′:6′,2′′-terpyridine Pt(II) coordination compound (tpy1Pt) is a potential candidate for next-generation mitophagy-targeting dinuclear Pt(II)-based anticancer drugs.

An Aggregation Induced Emission Binuclear Pt(II) Complex with Mitochondria Targeting and Cell Necrosis Inducing Capability

Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.

A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells.

An AIE-based Monofunctional Pt(ii) Complex for Photodynamic Therapy Through Synergism of Necroptosis–ferroptosis

Targeted Theranostic Platinum(Iv) Prodrug With A Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor For Noninvasive Early Evaluation Of Its Therapeutic Responses In Situ

Mitochondrial DNA-targeting and impairment by a dinuclear Ir-Pt complex that overcomes cisplatin resistance

All-in-One Molecular Aggregation-Induced Emission Theranostics: Fluorescence Image Guided and Mitochondria Targeted Chemo- and Photodynamic Cancer Cell Ablation

Synthesis and anticancer mechanisms of four novel platinum(II) 4′-substituted-2,2′:6′,2′′-terpyridine complexes

Enhancing Cytotoxicity of a Monofunctional Platinum Complex Via a Dual-DNA-Damage Approach.

Photodamaging of Mitochondrial DNA to Overcome Cisplatin Resistance by a Ru II -Pt II Bimetallic Complex.

Mitochondria-targeted Platinum(ii) Complexes Induce Apoptosis-Dependent Autophagic Cell Death Mediated by ER-stress in A549 Cancer Cells

A NIR‐Light‐Activated and Lysosomal‐Targeted Pt (II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

A Platinum(II) Boron-dipyrromethene Complex for Cellular Imaging and Mitochondria-targeted Photodynamic Therapy in Red Light

Synthesis and Photoactivity of a Pt(II) Complex Based on an O-Nitrobenzyl-derived Ligand

A Pt(II) complex bearing N-heterocycle ring induced ferroptotic cell death in ovarian cancer

Mitochondria-Targeted Polydopamine Nanocomposite with AIE Photosensitizer for Image-Guided Photodynamic and Photothermal Tumor Ablation

A Mitochondria-Targeting Dinuclear Ir-Ru Complex As a Synergistic Photoactivated Chemotherapy and Photodynamic Therapy Agent Against Cisplatin-Resistant Tumour Cells.

Aggregation-induced near-infrared emitting platinum(ii) terpyridyl complex: cellular characterisation and lysosome-specific localisation.

A Mitochondria Targeting Ir(III) Complex Triggers Ferroptosis and Autophagy for Cancer Therapy: A Case of Aggregation Enhanced PDT Strategy for Metal Complexes

Ruthenium(II) Polypyridyl Complexes As Mitochondria-Targeted Two-Photon Photodynamic Anticancer Agents